Not yet recruitingNot applicableNCT02978677

Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas

Studying Meningioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Technische Universität Dresden
Principal Investigator
Mechthild Krause, Prof.
Technische Universität Dresden, German Cancer Consortium, Helmholtz-Zentrum Dresden - Rossendorf
Intervention
Radiotherapy 68 Gy(RBE)(radiation)
Enrollment
90 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2029

Collaborators

German Cancer Research Center · Radiation Oncology Working Group of the German Cancer Society

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02978677 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma →

← Back to all trials